Clinical trials sponsored by AC Camargo Cancer Center

Phase breakdown

Conditions studied

Recruiting trials led by AC Camargo Cancer Center

• Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer
  NCT04993014 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
  NCT06472388 · Phase: Phase 2 · Ages: 16 Years and older · Sex: All (male and female) · 2 locations
• Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
  NCT06793137 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma
  NCT07680699 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
  NCT07285356 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is AC Camargo Cancer Center recruiting for?

AC Camargo Cancer Center is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.